Clinical Trial Update: A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)] [Phase 2]

View source ↗

Summary

Phase 2 clinical study of LBL-024 in combination therapy for advanced solid tumors is currently recruiting, with substudy focusing on biliary tract cancer and h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• LBL-024

Snippet

Sponsor: Nanjing Leads Biolabs Co.,Ltd | Conditions: Advanced Solid Tumour | Phase 2 | Status: RECRUITING